Navigating Setbacks: The Future of Psychedelic Medicine

Show Notes

In this episode, Dr. Dave Rabin engages in a thought-provoking conversation with Skippy Mesirow. They delve into the evolving landscape of psychedelic medicine, discussing recent setbacks in the FDA's decision regarding MDMA-assisted therapy and the implications for the broader psychedelic community. Skippy shares his journey as a facilitator in the psychedelic space, offering insights from his work in Colorado's movement and innovative approaches in Aspen. Together, they discuss the vital role of community, compassion, and collaboration in advancing therapies, reflect on the healing and creative energy of Burning Man, and emphasize the importance of unity among advocates for decriminalization and legalization.

Tune in for an inspiring call to action and valuable insights from two dedicated leaders in the field.

Instagram: https://www.instagram.com/skippymesirow/
Web: https://www.electedleaderscollective.com/
Twitter: https://twitter.com/DrDavidRabin
Instagram: https://www.instagram.com/drdavidrabin
Web: https://www.drdave.io/